PerkinElmer Inc to buy Germany's Euroimmun

By Ben Mouncer
PerkinElmer Inc is to buy Germany's Euroimmun Medical Laboratory Diagnostics AG in a deal worth $1.3bn. The scientific instruments maker is looking to...

PerkinElmer Inc is to buy Germany's Euroimmun Medical Laboratory Diagnostics AG in a deal worth $1.3bn.

The scientific instruments maker is looking to expand its reach into autoimmune and allergy diagnostic markets and Euroimmun is recognised as a lead autoimmune testing company in infectious disease and allergy testing.

It employs 2,400 members of staff and has recorded an average revenue growth of 19% over the last five years, generating sales in more than 130 countries worldwide.

45% of its revenues come in China, with the buy-out giving PerkinElmer Inc new infectious disease capabilities to its customers in the Asian country.

The deal could add up to $0.30 per share to Perkin Elmer Inc’s 2018 adjusted earnings, with the transaction expected to complete in the final quarter of this year.

First quarter numbers for Perkin Elmer Inc revealed revenues of $514.12m, nearly $8m up on the predicted figure of $506.81m.

Share

Featured Articles

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Joanna Smith, Digital Advisory Lead at consulting company Lexica, explores the impact of COVID-19 on digital healthcare & what role health data can play

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma

AutoRABIT CEO Meredith Bell on DevOps strategy in healthcare

Hospitals